centrifugal spinning; microfibre; amorphous solid dispersion; sucrose; poorly water-soluble drug; itraconazole; dissolution enhancement; supersaturation; tabletting; oral formulation

Marano, Stefania ORCID: 0000-0001-7686-2924 , Ghimire, Manish, Missaghi, Shahrzad, Rajabi-Siahboomi, Ali, Craig, Duncan Q. M. ORCID: 0000-0003-1294-8993 and Barker, Susan ORCID: 0000-0003-4880-0253 (2023) Development of robust tablet formulations with enhanced drug dissolution profiles from centrifugally-spun micro-fibrous solid dispersions of itraconazole, a BCS class II drug. Pharmaceutics, 15 (3):802. pp. 1-28. ISSN 1999-4923 (Online) (doi:https://doi.org/10.3390/pharmaceutics15030802)

direct ink writing, polycaprolactone, polyethylene oxide, ink rheology, material characterisation, 3D construct

Zhang, Bin, Chung, Se Hun, Barker, Susan, Craig, Duncan, Narayan, Roger J and Huang, Jie (2020) Direct ink writing of polycaprolactone / polyethylene oxide based 3D constructs. Progress in Natural Science: Materials International, 31. pp. 180-191. ISSN 1002-0071 (doi:https://doi.org/10.1016/j.pnsc.2020.10.001)

electrospinning, electrospun nanofibers, solvent-casting, orodispersible films (ODFs), prednisolone, disintegration, dissolution, e-tongue

Tawfik, Essam A, Scarpa, Mariagiovanna, Adbelhakim, Hend E, Bukhary, Haitham A, Craig, Duncan Q M, Barker, Susan A and Orlu, Mine (2021) A Potential Alternative Orodispersible Formulation to Prednisolone Sodium Phosphate Orally Disintegrating Tablets. Pharmaceutics, 13:120. ISSN 1999-4923 (doi:https://doi.org/10.3390/pharmaceutics13010120)

in vitro; in vivo; biological assessment; coaxial nanofibers; corneal abrasion

Tawfik, Essam A., Alshamsan, Aws, Abul Kalam, Mohd, Raish, Mohammad, Alkholief, Musaed, Stapleton, Paul, Harvey, Kirsten ORCID: 0000-0002-1291-0728 , Craig, Duncan Q.M. and Barker, Susan (2021) In vitro and in vivo biological assessment of dual drug-loaded coaxial nanofibers for the treatment of corneal abrasion. International Journal of Pharmaceutics, 604:120732. ISSN 0378-5173 (Print), 1873-34766 (Online) (doi:https://doi.org/10.1016/j.ijpharm.2021.120732)